Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Abroad (travel likely)RecruitingPHASE2

Conditions

Salivary Gland Cancer · HER2 Gene Mutation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Winship Cancer Institute, Emory University, Atlanta, Georgia, United States
Contact: Study coordinator (Conor Steuer, MD) · csteuer@emory.edu · 404-778-5378
University of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Alexander T Pearson, MD, PhD) · apearson5@medicine.bsd.uchicago.edu · 855-702-8222
Contact: Study coordinator (Cancer Clinical Trials Office) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
Contact: Principal Investigator (Alexander T Pearson, MD, PhD)
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Glenn J Hanna, MD) · glenn_hanna@dfci.harvard.edu · 617-632-3090
Contact: Principal Investigator (Glenn J Hanna, MD)
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Glenn J. Hanna, MD) · glenn_hanna@dfci.harvard.edu · 617-632-3090
Contact: Principal Investigator (Glenn J. Hanna, MD)
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 833-637-1274
Contact: Principal Investigator (Alan L Ho, MD, PhD)
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 844-665-7394
Contact: Principal Investigator (Alan L Ho, MD, PhD)
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 551-751-1007
Contact: Principal Investigator (Alan L Ho, MD, PhD)
Memorial Sloan Kettering Commack, Commack, New York, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 833-637-1274
Contact: Principal Investigator (Alan L Ho, MD, PhD)
Memorial Sloan Kettering Westchester, Harrison, New York, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 914-893-4461
Contact: Principal Investigator (Alan L Ho, MD, PhD)
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 833-637-1274
Contact: Principal Investigator (Alan L Ho, MD, PhD)
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 646-733-4430
Contact: Principal Investigator (Alan L Ho, MD, PhD)
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Contact: Study coordinator (Alan L Ho, MD, PhD) · 516-564-2022
Contact: Principal Investigator (Alan L Ho, MD, PhD)
University of Washington Medical Center, Seattle, Washington, United States
Contact: Study coordinator (Jay Liao, MD)
Contact: Principal Investigator (Jay Liao, MD)

Study leads

Glenn J Hanna, MD
Principal Investigator
Dana-Farber Cancer Institute

View source on ClinicalTrials.gov Contact study team (email)